Related references
Note: Only part of the references are listed.Protein kinase inhibitors for amyotrophic lateral sclerosis therapy
Valle Palomo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels
Jimmy Beckers et al.
AUTOPHAGY (2021)
Molecular Mechanisms Underlying TDP-43 Pathology in Cellular and Animal Models of ALS and FTLD
Alistair Wood et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
A RIPK1-regulated inflammatory microglial state in amyotrophic lateral sclerosis
Lauren Mifflin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Distinct responses of human peripheral blood cells to different misfolded protein oligomers
Magdalena Leal-Lasarte et al.
IMMUNOLOGY (2021)
Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis
Jessica Root et al.
NEUROBIOLOGY OF DISEASE (2021)
Translational evidence for lithium-induced brain plasticity and neuroprotection in the treatment of neuropsychiatric disorders
Stefano Puglisi-Allegra et al.
TRANSLATIONAL PSYCHIATRY (2021)
Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial
Jesus S. Mora et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2020)
Dysregulation of Rac or Rho elicits death of motor neurons and activation of these GTPases is altered in the G93A mutant hSOD1 mouse model of amyotrophic lateral sclerosis
Trisha R. Stankiewicz et al.
NEUROBIOLOGY OF DISEASE (2020)
The multifaceted role of kinases in amyotrophic lateral sclerosis: genetic, pathological and therapeutic implications
Wenting Guo et al.
BRAIN (2020)
The Overlapping Genetics of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Yevgeniya A. Abramzon et al.
FRONTIERS IN NEUROSCIENCE (2020)
Leucine Rich Repeat Kinase 2 and Innate Immunity
Diba Ahmadi Rastegar et al.
FRONTIERS IN NEUROSCIENCE (2020)
Metformin and Its Benefits for Various Diseases
Ziquan Lv et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
GSK3: A Kinase Balancing Promotion and Resolution of Inflammation
Leonie Hoffmeister et al.
CELLS (2020)
Development of disease-modifying drugs for frontotemporal dementia spectrum disorders
Francesco Panza et al.
NATURE REVIEWS NEUROLOGY (2020)
The Loss of TBK1 Kinase Activity in Motor Neurons or in All Cell Types Differentially Impacts ALS Disease Progression in SOD1 Mice
Valeria Gerbino et al.
NEURON (2020)
From basic research to the clinic: innovative therapies for ALS and FTD in the pipeline
Rajka Maria Liscic et al.
MOLECULAR NEURODEGENERATION (2020)
Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target
Lauren Mifflin et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Metformin inhibits RAN translation through PKR pathway and mitigates disease in C9orf72 ALS/FTD mice
Tao Zu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
ALS-associated TBK1 variant p.G175S is defective in phosphorylation of p62 and impacts TBK1-mediated signalling and TDP-43 autophagic degradation
A. D. Foster et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2020)
Interferon-γ signaling synergizes with LRRK2 in neurons and microglia derived from human induced pluripotent stem cells
Vasiliki Panagiotakopoulou et al.
NATURE COMMUNICATIONS (2020)
RACK1 Mediates NLRP3 Inflammasome Activation by Promoting NLRP3 Active Conformation and Inflammasome Assembly
Yanhui Duan et al.
CELL REPORTS (2020)
Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs
Manoj Kumar Jaiswal
MEDICINAL RESEARCH REVIEWS (2019)
Involvement of AMP-activated protein kinase in neuroinflammation and neurodegeneration in the adult and developing brain
Mariko Saito et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2019)
ROCK inhibition improves axonal regeneration in a preclinical model of amyotrophic lateral sclerosis
Abhijeet R. Joshi et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2019)
Implications of Microglia in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Henriette Haukedal et al.
JOURNAL OF MOLECULAR BIOLOGY (2019)
Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies
David R. Beers et al.
LANCET NEUROLOGY (2019)
Deletion of Tbk1 disrupts autophagy and reproduces behavioral and locomotor symptoms of FTD-ALS in mice
Weisong Duan et al.
AGING-US (2019)
Differential Interactome and Innate Immune Response Activation of Two Structurally Distinct Misfolded Protein Oligomers
Benedetta Mannini et al.
ACS CHEMICAL NEUROSCIENCE (2019)
The Missing Heritability of Sporadic Frontotemporal Dementia: New Insights from Rare Variants in Neurodegenerative Candidate Genes
Miriam Ciani et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
LRRK2 regulation of immune-pathways and inflammatory disease
Rebecca L. Wallings et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2019)
Peripheral loss of EphA4 ameliorates TBI-induced neuroinflammation and tissue damage
Elizabeth A. Kowalski et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Effects of ALS-associated TANK binding kinase 1 mutations on protein-protein interactions and kinase activity
Junqiang Ye et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Inflammation in ALS/FTD pathogenesis
Madelyn E. McCauley et al.
ACTA NEUROPATHOLOGICA (2019)
Reducing EphA4 before disease onset does not affect survival in a mouse model of Amyotrophic Lateral Sclerosis
Laura Rue et al.
SCIENTIFIC REPORTS (2019)
Heterozygous Tbk1 loss has opposing effects in early and late stages of ALS in mice
David Brenner et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases
Junying Yuan et al.
NATURE REVIEWS NEUROSCIENCE (2019)
TDP-43 knockdown causes innate immune activation via protein kinase R in astrocytes
Thomas J. LaRocca et al.
NEUROBIOLOGY OF DISEASE (2019)
ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?
Rita Mejzini et al.
FRONTIERS IN NEUROSCIENCE (2019)
ALS-associated missense and nonsense TBK1 mutations can both cause loss of kinase function
Martina de Majo et al.
NEUROBIOLOGY OF AGING (2018)
Antisense-mediated reduction of EphA4 in the adult CNS does not improve the function of mice with amyotrophic lateral sclerosis
Karen K. Ling et al.
NEUROBIOLOGY OF DISEASE (2018)
Regulation of a distinct activated RIPK1 intermediate bridging complex I and complex II in TNFα-mediated apoptosis
Palak Amin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
An increase in LRRK2 suppresses autophagy and enhances Dectin-1-induced immunity in a mouse model of colitis
Tetsuya Takagawa et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging
Daichao Xu et al.
CELL (2018)
Decreased signalling of EphA4 improves functional performance and motor neuron survival in the SOD1G93A ALS mouse model
J. Zhao et al.
SCIENTIFIC REPORTS (2018)
Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 4
Isabella Russo et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS
Emiliano Trias et al.
JCI INSIGHT (2018)
Extracellular TDP-43 aggregates target MAPK/MAK/MRK overlapping kinase (MOK) and trigger caspase-3/IL-18 signaling in microglia
Maria M. Leal-Lasarte et al.
FASEB JOURNAL (2017)
Increased cytoplasmic TDP-43 reduces global protein synthesis by interacting with RACK1 on polyribosomes
Arianna Russo et al.
HUMAN MOLECULAR GENETICS (2017)
Repetitive element transcripts are elevated in the brain of C9orf72 ALS/FTLD patients
Mercedes Prudencio et al.
HUMAN MOLECULAR GENETICS (2017)
TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis
Julie van der Zee et al.
HUMAN MUTATION (2017)
Identification and characterization of Nanobodies targeting the EphA4 receptor
Lies Schoonaert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
LRRK2 promotes the activation of NLRC4 inflammasome during Salmonella Typhimurium infection
Weiwei Liu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Knockdown of miR-155 protects microglia against LPS-induced inflammatory injury via targeting RACK1: a novel research for intracranial infection
Haiyan Yin et al.
JOURNAL OF INFLAMMATION-LONDON (2017)
Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases
Philip A. Harris et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
A neuroprotective astrocyte state is induced by neuronal signal EphB1 but fails in ALS models
Giulia E. Tyzack et al.
NATURE COMMUNICATIONS (2017)
Modulation of Microglial Activity by Rho-Kinase (ROCK) Inhibition as Therapeutic Strategy in Parkinson's Disease and Amyotrophic Lateral Sclerosis
Anna-Elisa Roser et al.
FRONTIERS IN AGING NEUROSCIENCE (2017)
TBK1: a new player in ALS linking autophagy and neuroinflammation
James A. Oakes et al.
MOLECULAR BRAIN (2017)
Rho Kinase Inhibition with Fasudil in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis-Symptomatic Treatment Potential after Disease Onset
Rene Guenther et al.
FRONTIERS IN PHARMACOLOGY (2017)
Evidence for mast cells contributing to neuromuscular pathology in an inherited model of ALS
Emiliano Trias et al.
JCI INSIGHT (2017)
Potent and Selective EphA4 Agonists for the Treatment of ALS
Bainan Wu et al.
CELL CHEMICAL BIOLOGY (2017)
AMPK Signalling and Defective Energy Metabolism in Amyotrophic Lateral Sclerosis
Nirma D. Perera et al.
NEUROCHEMICAL RESEARCH (2016)
Protein Kinase C Enzymes in the Hematopoietic and Immune Systems
Amnon Altman et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 34 (2016)
Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis
Emiliano Trias et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Mechanisms of ephrin-Eph signalling in development, physiology and disease
Artur Kania et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
Dynamic recruitment and activation of ALS-associated TBK1 with its target optineurin are required for efficient mitophagy
Andrew S. Moore et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS
Yasushi Ito et al.
SCIENCE (2016)
How neuroinflammation contributes to neurodegeneration
Richard M. Ransohoff
SCIENCE (2016)
The 'Omics' of Amyotrophic Lateral Sclerosis
Diana Caballero-Hernandez et al.
TRENDS IN MOLECULAR MEDICINE (2016)
Human TBK1: A Gatekeeper of Neuroinflammation
Liyana Ahmad et al.
TRENDS IN MOLECULAR MEDICINE (2016)
Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease
Cyril Pottier et al.
ACTA NEUROPATHOLOGICA (2015)
Emerging mechanisms of molecular pathology in ALS (vol 125, pg 1767, 2015)
Owen M. Peters et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Leucine-rich repeat kinase 2 positively regulates inflammation and down-regulates NF-κB p50 signaling in cultured microglia cells
Isabella Russo et al.
JOURNAL OF NEUROINFLAMMATION (2015)
Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia
Axel Freischmidt et al.
NATURE NEUROSCIENCE (2015)
Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohort
Ilse Gijselinck et al.
NEUROLOGY (2015)
Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways
Elizabeth T. Cirulli et al.
SCIENCE (2015)
Chatting with the neighbors: crosstalk between Rho-kinase (ROCK) and other signaling pathways for treatment of neurological disorders
Niko Hensel et al.
FRONTIERS IN NEUROSCIENCE (2015)
RIP kinases: key decision makers in cell death and innate immunity
F. Humphries et al.
CELL DEATH AND DIFFERENTIATION (2015)
Increased expression of Myosin binding protein H in the skeletal muscle of amyotrophic lateral sclerosis patients
Antonio Conti et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Rho Kinase Inhibition Modulates Microglia Activation and Improves Survival in a Model of Amyotrophic Lateral Sclerosis
Lars Toenges et al.
GLIA (2014)
Inhibition of the microglial response is essential for the neuroprotective effects of Rho-kinase inhibitors on MPTP-induced dopaminergic cell death
Ana Borrajo et al.
NEUROPHARMACOLOGY (2014)
Rho Kinase Inhibitor Fasudil Regulates Microglia Polarization and Function
Haifei Zhang et al.
NEUROIMMUNOMODULATION (2013)
Unconventional Translation of C9ORF72 GGGGCC Expansion Generates Insoluble Polypeptides Specific to c9FTD/ALS
Peter E. A. Ash et al.
NEURON (2013)
RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia
Tao Zu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS
Kohji Mori et al.
SCIENCE (2013)
(G2019S) LRRK2 activates MKK4-JNK pathway and causes degeneration of SN dopaminergic neurons in a transgenic mouse model of PD
C-Y Chen et al.
CELL DEATH AND DIFFERENTIATION (2012)
Nogo-66 inhibits adhesion and migration of microglia via GTPase Rho pathway in vitro
Jun Yan et al.
JOURNAL OF NEUROCHEMISTRY (2012)
EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans
Annelies Van Hoecke et al.
NATURE MEDICINE (2012)
Transposable Elements in TDP-43-Mediated Neurodegenerative Disorders
Wanhe Li et al.
PLOS ONE (2012)
A novel role for RIP1 kinase in mediating TNFα production
D. E. Christofferson et al.
CELL DEATH & DISEASE (2012)
The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease
Zhihua Liu et al.
NATURE IMMUNOLOGY (2011)
Metformin Treatment Has No Beneficial Effect in a Dose-Response Survival Study in the SOD1G93A Mouse Model of ALS and Is Harmful in Female Mice
Hannah M. Kaneb et al.
PLOS ONE (2011)
Regulation by glycogen synthase kinase-3 of inflammation and T cells in CNS diseases
Eleonore Beurel
FRONTIERS IN MOLECULAR NEUROSCIENCE (2011)
Riluzole, Neuroprotection and Amyotrophic Lateral Sclerosis
B. C. Cheah et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Fasudil protects hippocampal neurons against hypoxia-reoxygenation injury by suppressing microglial inflammatory responses in mice
Jing Ding et al.
JOURNAL OF NEUROCHEMISTRY (2010)
LRRK2 and the Stress Response: Interaction with MKKs and JNK-Interacting Proteins
C. H. Hsu et al.
NEURODEGENERATIVE DISEASES (2010)
Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis
Michael J. Strong et al.
AMYOTROPHIC LATERAL SCLEROSIS (2009)
The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7, in vitro
Christian Johannes Gloeckner et al.
JOURNAL OF NEUROCHEMISTRY (2009)
The Parkinson Disease Protein Leucine-Rich Repeat Kinase 2 Transduces Death Signals via Fas-Associated Protein with Death Domain and Caspase-8 in a Cellular Model of Neurodegeneration
Cherry Cheng-Ying Ho et al.
JOURNAL OF NEUROSCIENCE (2009)
Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT
Patrice Dubreuil et al.
PLOS ONE (2009)
Lrrk2 G2019S substitution in frontotemporal lobar degeneration with ubiquitin-immunoreactive neuronal inclusions
Justus C. Dachsel et al.
ACTA NEUROPATHOLOGICA (2007)
Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo
W Noble et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Axonal regeneration and lack of astrocytic gliosis in EphA4-deficient mice
Y Goldshmit et al.
JOURNAL OF NEUROSCIENCE (2004)
Protein kinase and protein phosphatase expression in amyotrophic lateral sclerosis spinal cord
JH Hu et al.
JOURNAL OF NEUROCHEMISTRY (2003)
The overlap of amyotrophic lateral sclerosis and frontotemporal dementia
C Lomen-Hoerth et al.
NEUROLOGY (2002)
A novel neuroprotective mechanism of riluzole: Direct inhibition of protein kinase C
KM Noh et al.
NEUROBIOLOGY OF DISEASE (2000)
Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection
S Balachandran et al.
IMMUNITY (2000)
Share Paper
